|
Re: 47 Taken out by Gilead for $4.9 billion
|
4
|
Resverlogix Corp.
|
Mar 05, 2020 09:14AM
|
|
Re: Questions for Q1 webcast
|
4
|
Resverlogix Corp.
|
Mar 05, 2016 09:08PM
|
|
Re: Reading (parsing, fantasizing) the tea leaves
|
4
|
Resverlogix Corp.
|
Feb 01, 2021 10:28AM
|
|
Re: Value
|
4
|
Resverlogix Corp.
|
Jan 20, 2017 09:49PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 14, 2022 06:46AM
|
|
Canadian government support for business
|
4
|
Resverlogix Corp.
|
May 11, 2020 03:10PM
|
|
Re: MERCK….
|
4
|
Resverlogix Corp.
|
Oct 04, 2021 11:17AM
|
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 06, 2019 11:32AM
|
|
Re: TD & Zen over the weekend..
|
4
|
Resverlogix Corp.
|
Aug 12, 2019 02:46PM
|
|
Re: Conspiracy Theory(s) do things like this happen?
|
4
|
Resverlogix Corp.
|
Jan 19, 2023 02:44PM
|
|
Re: Yahoo poster claims a reverse split coming....
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 01:57PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
4
|
Zenith Epigenetics
|
Oct 15, 2024 12:11PM
|
|
RVX 297 publication news from rndtbl from IV
|
4
|
Resverlogix Corp.
|
Oct 03, 2017 08:47AM
|
|
Re: Cash burn and the cost of servicing the loan....
|
4
|
Resverlogix Corp.
|
Apr 16, 2018 12:42PM
|
|
Nature article on apabetalone and HIV, hope this wakes up the market
|
4
|
Resverlogix Corp.
|
Dec 12, 2017 07:49AM
|
|
Re: Amarin CEO interview - New class action lawsuit
|
4
|
Resverlogix Corp.
|
Nov 14, 2018 08:32PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
4
|
Zenith Epigenetics
|
Jul 26, 2019 10:50AM
|
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Jan 30, 2024 04:37PM
|
|
Re: Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction
|
4
|
Resverlogix Corp.
|
Aug 28, 2017 10:36AM
|
|
Re: MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 04, 2018 10:46AM
|
